STAT Plus: Pharmalittle: Novartis says coronavirus not disrupting supply chain, for now; FDA releases new gene therapy policies
Good morning, everyone, and welcome to the middle of the week. You made it this far, so why not continue? Consider the alternatives, after all. Meanwhile, we would like to note the passing of the Morning Mayor, who taught us a valuable lesson: Every new day should be unwrapped like a precious gift. While you tug on the ribbon, you can also peruse some of the items we have assembled below. Hope your day goes well and please do keep in touch. We appreciate your tips, criticism and suggestions.
Novartis (NVS) is not seeing any disruption to its supply chain due to the coronavirus outbreak, Reuters reports. The company has asked its staff in China to work from home until Feb. 10 while suspending business travel to and from Wuhan, the city where the coronavirus is believed to have emerged from a food market. Novartis chief executive Vas Narasimhan says the situation was developing very quickly and must be monitored, but for now he believes its business will emerge unscathed.
Continue to STAT Plus to read the full story…
